Latest Content

The dual glucagon/GLP-1 receptor agonist is also being studied in the SYNCHRONIZE-2, SYNCHRONIZE-CVOT, LIVERAGE, and LIVERAGE-Cirrhosis trials.

Real-world diabetic macular edema care lags trials as fewer VEGF injections and step therapy limit outcomes.

A total of 2288 cases of measles were confirmed in the US for the full year of 2025, suggesting that the cases are set to double in 2026.

Learn how payer fee schedules impact practices, curb administrative costs in healthcare, and boost revenue with audits, tech, and smarter contracts.

The authors evaluated changes in persistence to basal insulin in a Medicare Advantage population in the first year of the Medicare insulin out-of-pocket cost cap.

Remote therapeutic monitoring (RTM) with ePROs powered by AI cuts hospitalizations and boosts therapy time—now a key oncology leader promotes guideliens and reimbursement to make it standard of care.

Four experts examine what updated dietary and obesity guidelines mean for diabetes care, and why personalized, equitable nutrition is now essential.

Diet quality, carbohydrate quantity, and macronutrient composition may influence gestational glycemia, with consequences well into the postpartum period.

The next frontier, according to Igor Puzanov, MD, MSCI, FACP, includes improving immune toxicity recognition and long-term care.